Impact of circulating tumor cell (CTC) nucleus size on outcomes with abiraterone acetate (AA) therapy in men with metastatic castration-resistant prostate cancer (mCRPC).
David Gill(Intermountain Healthcare), Archana M. Agarwal(University of Utah), Emma Carroll(University of Utah), Austin Poole(University of Utah), Kenneth M. Boucher(University of Utah), Eric O. Johnson(RTI International), Andrew W. Hahn(The University of Texas MD Anderson Cancer Center), Neeraj Agarwal(University of Utah), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center)
Cited by 4
Related Papers
Variants in Nicotinic Receptors and Risk for Nicotine Dependence
|American Journal of Psychiatry|2008|641
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genome-wide association study of alcohol dependence
|Proceedings of the National Academy of Sciences|2010|461
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441